# Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-operator-financial-performance-patient-access/ > **Published:** 2026-03-31T21:03:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:33:36-04:00 > **Clinical Summary:** Explore cannabis operator financial performance and its impact on patient access and supply chain stability in the medical cannabis market. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Market AccessSupply Chain[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Patient Access[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/) Why This Matters Corporate financial performance of cannabis operators directly impacts product availability, pricing stability, and research investment that affects patient access to medical cannabis. Market consolidation and financial health of operators influences the consistency of supply chains that patients depend on for therapeutic regimens. Clinical Summary Jushi Holdings, a multi-state cannabis operator, reported financial results for Q4 and full year 2024 (note: the title incorrectly states 2025). Without access to specific financial metrics from this report, cannabis operator earnings typically reflect market performance, regulatory impacts, and operational efficiency across their dispensary and cultivation footprint. Financial stability of licensed operators affects product quality control, inventory consistency, and pricing accessibility for medical patients. Dr. Caplan’s Take “I watch cannabis operator financials because unstable companies mean unstable patient access – and my patients need predictable supply of consistent products for their medical regimens. A volatile market ultimately translates to unpredictable medicine availability at the pharmacy level.” Clinical Perspective 🧠 Clinicians should be aware that cannabis market volatility affects patient access to specific products and formulations. When operators face financial pressure, product lines may be discontinued or pricing may fluctuate significantly, potentially disrupting established therapeutic protocols. Consider discussing supply chain backup options with patients using cannabis therapeutically. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Jushi%20Holdings%20Inc.%20Reports%20Fourth%20Quarter%20and%20Full%20Year%202025%20Financial%20Results%20%40drcaplan&url=https%3A//ir.jushico.com/news-events/press-releases/detail/323/jushi-holdings-inc-reports-fourth-quarter-and-full-year)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//ir.jushico.com/news-events/press-releases/detail/323/jushi-holdings-inc-reports-fourth-quarter-and-full-year)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Jushi%20Holdings%20Inc.%20Reports%20Fourth%20Quarter%20and%20Full%20Year%202025%20Financial%20Results%20--%20via%20%40drcaplan.bsky.social%20https%3A//ir.jushico.com/news-events/press-releases/detail/323/jushi-holdings-inc-reports-fourth-quarter-and-full-year)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://ir.jushico.com/news-events/press-releases/detail/323/jushi-holdings-inc-reports-fourth-quarter-and-full-year](https://ir.jushico.com/news-events/press-releases/detail/323/jushi-holdings-inc-reports-fourth-quarter-and-full-year) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What areas of medical cannabis does this article cover?](#What_areas_of_medical_cannabis_does_this_article_cover) - [Why is this considered emerging information?](#Why_is_this_considered_emerging_information) - [How does this relate to patient care?](#How_does_this_relate_to_patient_care) - [What should healthcare providers do with this information?](#What_should_healthcare_providers_do_with_this_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned a CED Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This means the findings or policy developments are emerging and worth monitoring closely by healthcare professionals. #### What areas of medical cannabis does this article cover? The article focuses on four key areas: market access, supply chain issues, medical cannabis developments, and patient access concerns. These topics are interconnected aspects of the medical cannabis landscape that affect clinical practice. #### Why is this considered emerging information? The article is marked as “New” content from CED Clinic, suggesting recent developments in cannabis policy or clinical findings. The “Notable Clinical Interest” designation indicates these are evolving situations that require ongoing attention from healthcare providers. #### How does this relate to patient care? Patient access is specifically highlighted as one of the key focus areas. This suggests the article contains information that could directly impact how patients obtain and use medical cannabis treatments. #### What should healthcare providers do with this information? Given the “Notable Clinical Interest” rating, healthcare providers should monitor these developments closely. The emerging nature of the findings suggests they may influence future medical [cannabis prescribing](https://cedclinic.com/addressing-cannabis-education-gap-clinical-care/) practices or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) protocols. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results”, “url”: “https://ir.jushico.com/news-events/press-releases/detail/323/jushi-holdings-inc-reports-fourth-quarter-and-full-year”, “datePublished”: “2026-03-31T20:02:12Z”, “about”: “jushi holdings inc reports fourth quarter”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis sales plummet as regulators crack down on booming industry](https://cedclinic.com/cannabis-market-disruption-regulatory-crackdown/) Explore how regulatory actions are impacting cannabis sales and market stability, affecting operators and patient access. [Read More](https://cedclinic.com/cannabis-market-disruption-regulatory-crackdown/) [Greater Cannabis posts 2025 loss with no revenue | GCAN Annual Report (10-K)](https://cedclinic.com/cannabis-industry-financial-instability-2025-loss-patient-access/) Review financial challenges faced by cannabis operators and their implications for market and patient access. [Learn More](https://cedclinic.com/cannabis-industry-financial-instability-2025-loss-patient-access/) [US: Critical updates for cannabis taxpayers as the 2025 filing deadline approaches](https://cedclinic.com/cannabis-tax-compliance-challenges-2025-filing-deadline/) Stay informed on important financial and regulatory updates affecting cannabis operators and the broader market. [Discover Updates](https://cedclinic.com/cannabis-tax-compliance-challenges-2025-filing-deadline/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).